Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07363759 · ClinicalTrials.gov registry record · NA
ISOVUE Comparative Trial
A NA study, sponsored by Rush University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
NCT07363759: Completed NA study, sponsored by Rush University Medical Center.
NCT07363759 is a NA study that has completed, run by Rush University Medical Center. The registered enrollment target is 56 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07363759, a NA study, has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
Study Summary
This study aimed to investigate a novel technique for intraoperative quantitative and qualitative feedback during discectomy and endplate preparation in TLIF.
Primary Outcome
Disc space clearance in the anteroposterior (AP) plane at the index level measured on oblique radiographs.
Interventions
- PROCEDURE ISOVUE 300 Observation
- PROCEDURE ISOVUE 300 Feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2019-04-11 |
| Est. Completion | 2023-06-19 |
| Phase | NA |
What the finished NCT07363759 record still lists
NCT07363759 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which ISOVUE 300 Observation is the first listed.
NCT07363759 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07363759 about?
NCT07363759 is a clinical study titled "ISOVUE Comparative Trial". This study aimed to investigate a novel technique for intraoperative quantitative and qualitative feedback during discectomy and endplate preparation in TLIF.
What is the current status of trial NCT07363759?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2019-04-11. Estimated completion is 2023-06-19.
What interventions are being tested in trial NCT07363759?
The interventions under investigation include: ISOVUE 300 Observation (PROCEDURE), ISOVUE 300 Feedback (PROCEDURE).
Who is sponsoring clinical trial NCT07363759?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07363759's enrollment target sits among peer trials
56 1262nd of 2000 higher than 737 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI